Mitologics is an innovative biotechnology company based in Paris area (France) focusing on detection of mitochondrial injury, a key regulator of cell death. Mitologics proposes screening services to detect the toxicity and efficacy of compounds by predictive assays (Seahorse analysis, ROS, mtDNA...) on isolated healthy or pathological mitochondrial and cellular models. Mitologics assays on isolated mitochondria from mouse liver and human hepatocytes are highly predictive of hepatotoxicity in human (Porceddu et al., 2012). Three proprietary screening platforms: • MiToxView®: predictive toxicity assays • MitoPathway®: efficacy assays on tumor mitochondria • MitoXpert®: mitochondrial targeting/protection.
Looking for a particular Mitologics employee's phone or email?
The Mitologics annual revenue was $5 million in 2026.
Annie Borgne-Sanchez is the Owner of Mitologics.
5 people are employed at Mitologics.
Mitologics is based in Paris, Île-de-France.
The NAICS codes for Mitologics are [541, 54171, 541713, 54, 5417].
The SIC codes for Mitologics are [87, 873].